Database Query Results : Vitamin B5,Pantothenic Acid, ,

VitB5, Vitamin B5,Pantothenic Acid: Click to Expand ⟱
Features:
Vitamin B5 (Pantothenic Acid) plays several roles in the brain, and emerging evidence suggests it may be relevant to Alzheimer’s disease (AD)—particularly through its involvement in acetylcholine synthesis, energy metabolism, and oxidative stress response.
-Precursor to Coenzyme A (CoA)
-CoA is essential for mitochondrial energy production, lipid metabolism, and acetylcholine synthesis.
-CoA + choline → acetylcholine. ACh levels are reduced in AD; B5 deficiency may worsen this.
-Pantothenic acid is indirectly involved in cysteamine production, via CoA turnover.
-cysteamine can cross the BBB and increases BDNF levels.
-Pantothenic Acid (D-calcium pantothenate) Most common, stable, and well-absorbed form, water soluable
-Heat(cooking) may degrade the B5.
-Adequate Intake is 5mg/day. Target 10-15mg/day (300–900 mg/day under supervision)

-must be replenished daily; no long-term storage
Beef liver (3 oz cooked)   ~8.3 mg
Sunflower seeds (1 oz)	   ~2.0 mg
Chicken (3 oz cooked)	   ~1.0 mg
Salmon (3 oz cooked)	   ~1.6 mg
Avocado (1 whole)	   ~1.0–2.0 mg
Egg (1 large)	           ~0.7 mg
Mushrooms (½ cup cooked)   ~1.5 mg


Scientific Papers found: Click to Expand⟱
4317- VitB5,    Unraveling the molecular mechanisms of vitamin deficiency in Alzheimer's disease pathophysiology
- Review, AD, NA
*Ach↑, *ROS↓, *Inflam↓, *p‑tau↓, *Aβ↓, *Acetyl-CoA↑, *ATP↑, *ChAT↑, *memory↑,
4323- VitB5,    Cerebral deficiency of vitamin B5 (d-pantothenic acid; pantothenate) as a potentially-reversible cause of neurodegeneration and dementia in sporadic Alzheimer's disease
- Study, AD, NA
*Risk↓, *Acetyl-CoA↑, *Ach↑, *neuroP↑,
4324- VitB5,    Substantively Lowered Levels of Pantothenic Acid (Vitamin B5) in Several Regions of the Human Brain in Parkinson’s Disease Dementia
- Study, AD, NA - Study, Park, NA
*Risk↓, *other↝, *other↝, *Ach↑, *Aβ↑, *other?,
4325- VitB5,    Localized Pantothenic Acid (Vitamin B5) Reductions Present Throughout the Dementia with Lewy Bodies Brain
- Study, AD, NA - Study, Park, NA
*Risk↑, *Dose↝, *Dose↓, *other↝,
4326- VitB5,    Cerebral Vitamin B5 (D-Pantothenic Acid) Deficiency as a Potential Cause of Metabolic Perturbation and Neurodegeneration in Huntington’s Disease
- in-vivo, HD, NA
*Risk↓, *neuroP↑, *other?, *Ach↑, *other↝, *eff↓, *other↝,
4328- VitB5,    cognitive_vitality_media/Pantethine-Cognitive-Vitality-For-Researchers.pdf">Pantethine
- Review, AD, NA
*BBB↝, *LDL↓, *lipid-P↓, *AST↓, *ALAT↓, *TGF-β↓, *adiP↑, *Inflam↓, TumCG↓, FASN↓,
4329- VitB5,    Long-Term Pantethine Treatment Counteracts Pathologic Gene Dysregulation and Decreases Alzheimer's Disease Pathogenesis in a Transgenic Mouse Model
- in-vivo, AD, NA
*Aβ↓, *Mood↑, *neuroP↑, *Inflam↓, *TNF-α↓, *BBB↝, *other↝, *Dose↝,
4330- VitB5,    Metabolic changes and inflammation in cultured astrocytes from the 5xFAD mouse model of Alzheimer’s disease: Alleviation by pantethine
- in-vivo, AD, NA
*neuroP↑, *Inflam↓, *ATP↑, *G6PD↑, *NADPH↑, *IL1β↓, *other↝,
4334- VitB5,    Pantethine treatment is effective in recovering the disease phenotype induced by ketogenic diet in a pantothenate kinase-associated neurodegeneration mouse model
- in-vivo, AD, NA
*neuroP↑, *motorD↑, *MMP↑, *OCR↑,
4335- VitB5,    Pantethine, a derivative of vitamin B(5) used as a nutritional supplement, favorably alters low-density lipoprotein cholesterol metabolism in low- to moderate-cardiovascular risk North American subjects: a triple-blinded placebo and diet-controlled investigation
- Trial, NA, NA
*LDL↓,
4336- VitB5,    Effectiveness of long-term treatment with pantethine in patients with dyslipidemia
- Trial, NA, NA
*LDL↓, *HDL↑,

* indicates research on normal cells as opposed to diseased cells
Total Research Paper Matches: 11

Pathway results for Effect on Normal Cells:


Redox & Oxidative Stress ⓘ

HDL↑, 1,   lipid-P↓, 1,   ROS↓, 1,  

Mitochondria & Bioenergetics ATP production, membrane potential, mitochondrial signaling, and dynamics (fission, fusion, mitophagy). It includes mitochondrial contributions to apoptosis, metabolism, and redox signaling. Mitochondrial dysfunction is a core driver of cancer metabolism, neurodegeneration, and age-related decline." style="cursor:help;color:#555;font-weight:normal;">ⓘ

ATP↑, 2,   MMP↑, 1,   OCR↑, 1,  

Core Metabolism/Glycolysis ⓘ

Acetyl-CoA↑, 2,   adiP↑, 1,   ALAT↓, 1,   G6PD↑, 1,   LDL↓, 3,   NADPH↑, 1,  

Transcription & Epigenetics ⓘ

Ach↑, 4,   other?, 2,   other↝, 7,  

Migration ⓘ

TGF-β↓, 1,  

Barriers & Transport BBB, epithelial layers), membrane transporters, ion channels, and water channels. It governs permeability, cellular uptake/efflux, tissue protection, and drug access to target compartments." style="cursor:help;color:#555;font-weight:normal;">ⓘ

BBB↝, 2,  

Immune & Inflammatory Signaling Inflammation group includes innate and adaptive immune pathways, cytokines, chemokines, pattern-recognition receptors, complement, and inflammasomes. It regulates host defense, tumor immunity, neuroinflammation, and chronic inflammatory disease processes." style="cursor:help;color:#555;font-weight:normal;">ⓘ

IL1β↓, 1,   Inflam↓, 4,   TNF-α↓, 1,  

Synaptic & Neurotransmission memory, and neuronal survival, and is especially relevant to Alzheimer’s and other neurodegenerative diseases." style="cursor:help;color:#555;font-weight:normal;">ⓘ

ChAT↑, 1,   p‑tau↓, 1,  

Protein Aggregation tau biology, proteolytic processing, and aggregate toxicity. It captures molecular features specific to neurodegenerative pathology but remains extensible to other aggregation disorders." style="cursor:help;color:#555;font-weight:normal;">ⓘ

Aβ↓, 2,   Aβ↑, 1,  

Drug Metabolism & Resistance ⓘ

Dose↓, 1,   Dose↝, 2,   eff↓, 1,  

Clinical Biomarkers Inflammation state | Microenvironment | Research-stage | | 28 | XIST | Epigenetic instability | Aggressiveness | Not yet clinical | | 29 | FOXM1 | High-risk biology | Aggressiveness | No routine testing | | 30 | TRIB3 | Stress adaptation | Aggressiveness | Mechanistic, not clinical | Core Liver & Systemic Biomarkers in Oncology | Marker | What It Reflects | Main Use in Cancer | Decision Impact | | --------- | ----------------------------------- | ----------------------------------------- | ----------- | | ALT | Hepatocellular injury | Baseline eligibility, toxicity monitoring | High | | AST | Liver + systemic injury | Detect liver injury, muscle involvement | High | | ALP | Cholestasis, bone turnover | Liver mets vs bone mets | High | | bilirubin | Hepatic clearance | Chemotherapy dosing | Critical | | albumin | Synthetic liver function, nutrition | Prognosis, frailty | High | | LDH | Tumor burden, hypoxia | Aggressiveness, prognosis | High | | INR | Liver synthetic failure | Treatment safety | High | Key Inflammatory / Host-Response Biomarkers Used in Oncology | Biomarker | What It Reflects | Main Use in Cancer | Clinical Decision Impact | | ------------------ | -------------------------------- | ---------------------------- | -------------------- | | C-reactive protein | Systemic inflammation | Prognosis, therapy tolerance | High | | ESR | Chronic inflammation | Disease activity trend | Moderate | | ferritin | Inflammation + iron status | Cachexia, cytokine load | High | | IL-6 | Cytokine signaling | Aggressiveness, cachexia | High (specialty use) | | LDH | Tumor burden + hypoxia | Risk stratification | Very high | | albumin | Nutritional & inflammatory state | Frailty, survival | Very high | </pre> " style="cursor:help;color:#555;font-weight:normal;">ⓘ

ALAT↓, 1,   AST↓, 1,  

Functional Outcomes cognitive performance, toxicity, and organism-level effects. It is intentionally mechanism-agnostic and anchors molecular data to real-world biological impact." style="cursor:help;color:#555;font-weight:normal;">ⓘ

memory↑, 1,   Mood↑, 1,   motorD↑, 1,   neuroP↑, 5,   Risk↓, 3,   Risk↑, 1,  
Total Targets: 35

Query results interpretion may depend on "conditions" listed in the research papers.
Such Conditions may include : 
  -low or high Dose
  -format for product, such as nano of lipid formations
  -different cell line effects
  -synergies with other products 
  -if effect was for normal or cancerous cells

Filter Conditions: Pro/AntiFlg:%  IllCat:%  CanType:%  Cells:%  prod#:368  Target#:%  State#:%  Dir#:%
  wNotes=0  sortOrder:rid,rpid

 

Home Page